Ciara Kelly, MBBCh, BAO, interim clinical director of the Sarcoma Oncology Service at Memorial Sloan Kettering Cancer Center, discusses ongoing studies to further improve the treatment of patients with gastrointestinal stromal tumor (GIST). Several ongoing clinical trials are particularly promising for patients with GIST and offer new treatment options, Kelly begins. An exciting development came […]
Ciara Kelly, MBBCh, BAO, interim clinical director, Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center, discusses the evaluation of DCC-3116 in combination with ripretinib (Qinlock) in patients with advanced gastrointestinal stromal tumor (GIST) in a Phase 1/2 clinical trial (NCT05957367). This trial is enrolling patients with advanced disease who have not previously received treatment with […]
Ciara Kelly, MBBCh, BAO, interim clinical director of the Sarcoma Oncology Service at Memorial Sloan Kettering Cancer Center (MSKCC), discusses the management of patients with gastrointestinal stromal tumors (GISTs), emphasizing the importance of testing for genetic abnormalities and explaining how she performs this testing in her own clinical practice. When treating patients with GIST, it […]
